Kinase inhibitors

1. A compound of formula (II)

or a therapeutically acceptable salt thereof, wherein

X 2 is selected from the group consisting of N and CR 2 ;

X 3 is selected from the group consisting of N and CR 3 ;

X 4 is selected from the group consisting of N and CR 4 ;

provided that only one of X 2 , X 3 , and X 4 is N;

R 1 is selected from the group consisting of hydrogen, alkoxyalkyl, alkoxycarbonyl, alkenyl, alkyl, alkylcarbonyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclealkyl, hydroxyalkyl, (NR A R B )carbonyl, (NR A R B )sulfonyl, and (NR A R B )sulfonylalkyl;

R 2 is selected from the group consisting of hydrogen, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, halo, haloalkoxy, haloalkyl, heteroaryl, heteroarylalkenyl, heteroarylalkoxy, heteroarylealkyl, heteroaryloxyalkyl, heterocycle, heterocyclealkenyl, heterocyclealkoxy, heterocyclealkyl, heterocycleoxyalkyl, hydroxy, hydroxyalkoxy, hydroxyalkyl, (NR C R D )alkenyl, (NR C R D )alkoxy, (NR C R D )alkyl, (NR C R D )alkynyl, (NR C R D )carbonylalkenyl, and (NR C R D )carbonylalkyl;

R 3 and R 4 are independently selected from the group consisting of hydrogen, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkyl, arylalkyl, aryloxy, aryloxyalkyl, halo, haloalkoxy, haloalkyl, heteroarylalkenyl, heteroarylalkoxy, heteroarylealkyl, heteroaryloxyalkyl, heterocycle, heterocyclealkenyl, heterocyclealkoxy, heterocyclealkyl, heterocycleoxyalkyl, hydroxy, hydroxyalkoxy, hydroxyalkyl, (NR C R D )alkenyl, (NR C R D )alkoxy, (NR C R D )alkyl, (NR C R D )alkynyl, (NR C R D )carbonylalkenyl, and (NR C R D )carbonylalkyl;

R 5 , R 6 , and R 7 are independently selected from the group consisting of hydrogen, alkoxy, alkoxyalkoxy, alkyl, halo, haloalkoxy, haloalkyl, hydroxy, and —NR E R F ;

L is selected from the group consisting of (CH 2 ) m N(R 10 )C(O)N(R 11 )(CH 2 ) n and CH 2 C(O)NR 10 , wherein each group is drawn with its left end attached to the phenyl ring substituted with R 5 , R 6 , and R 7 ;

m and n are independently 0 or 1;

R 10 and R 11 are independently selected from the group consisting of hydrogen and alkyl;

R 12 , R 13 , and R 14 are independently selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkoxysulfonyl, alkyl, alkylcarbonyl, alkylcarbonylalkyl, alkylcarbonyloxy, alkylthio, alkylthioalkyl, alkynyl, carboxy, carboxyalkyl, cyano, cyanoalkyl, ethylenedioxy, formyl, haloalkoxy, haloalkyl, halogen, hydroxy, hydroxyalkyl, mercapto, methylenedioxy, nitro, —NR G R H , (NR G R H )carbonyl, and (NR G R H ) sulfonyl;

R A and R B are independently selected from the group consisting of hydrogen and alkyl;

R C and R D are independently selected from the group consisting of hydrogen, alkenyl, alkyl, alkylcarbonyl, alkylsulfonyl, aryl, arylalkyl, arylcarbonyl, arylsulfonyl, haloalkylsulfonyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heteroarylsulfonyl, heterocycle, heterocyclealkyl, and heterocyclesulfonyl;

R E and R F are independently selected from the group consisting of hydrogen, alkyl, and alkylcarbonyl; and

R G and R H are independently selected from the group consisting of hydrogen, alkyl, alkylcarbonyl, aryl, and arylalkyl.

2. The compound according to claim 1 wherein

X 2 is N;

X 3 is CR 3 ; and

X 4 is CR 4 .

3. The compound according to claim 1 wherein

X 2 is CR 2 ;

X 3 is N; and

X 4 is CR 4 .

4. The compound according to claim 1 wherein

X 2 is CR 2 ;

X 3 is CR 3 ; and

X 4 is N.